CLINICAL TRIALS PROFILE FOR CLODERM
✉ Email this page to a colleague
All Clinical Trials for CLODERM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01714544 ↗ | Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis | Completed | Promius Pharma, LLC | Phase 4 | 2012-10-01 | The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days. |
NCT04358770 ↗ | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Completed | WAYCro | Phase 1 | 2018-03-02 | To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults |
NCT04358770 ↗ | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Completed | Taro Pharmaceuticals USA | Phase 1 | 2018-03-02 | To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLODERM
Condition Name
Clinical Trial Locations for CLODERM
Trials by Country
Clinical Trial Progress for CLODERM
Clinical Trial Phase
Clinical Trial Sponsors for CLODERM
Sponsor Name